A Multicenter , Retrospective, Real-world study Analyzing Persistence and Treatment Patterns in Psoriatic Arthritis Patients
Latest Information Update: 28 Dec 2022
At a glance
- Drugs Ixekizumab (Primary) ; Secukinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
Most Recent Events
- 28 Dec 2022 New trial record
- 14 Nov 2022 Results presented at the ACR Convergence 2022